Skip to content

Clinical risk score to predict bipolar depressive disorder in patients with depressive disorders.

Clinical risk score to predict bipolar depressive disorder in patients with depressive disorders.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20230629004
Enrollment
81
Registered
2023-06-29
Start date
2023-07-17
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

20% of patients of bipolar depressive disorder are often misdiagnosed as unipolar depression because the patients are usually in a depressive state result in delay and inappropriate of treatment. diagnosis prediction, bipolar depression, bipolar depressive disorder, bipolar disorder, clinical risk score

Interventions

The participants are diagnosed with bipolar disorder and have ever at least one major depressive episode,The participants are diagnosed with MDD
Diagnostic,Diagnostic
bipolar disorder group (case),Unipolar depressive disorder group(control)

Sponsors

Faculty of Medicine Naresuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.bipolar diorder group(case) 1.1 The patients who diagnosed with bipolar disorder and have ever had major depressive episode. 1.2 The patients have normal consciousness and can read , write in Thai. 1.3 Age between 18-60 years old. 2. Unipolar depressive disorder group (control) 2.1 The patients who diagnosed with major depressive disorder. 2.2 The patients have normal consciousness and can read , write in Thai. 2.3 Age between 18-60 years old.

Exclusion criteria

Exclusion criteria: 1.bipolar diorder group(case) 1.1 The patients with a psychiatric emergency or unstable condition requiring urgent treatment. 1.2 The patients diagnosed with schizophrenia, schizoaffective disorder, neurodevelopmental disorders such as intellectual disabilities, autism spectrum disorder, neurocognitive disorders including delirium and dementia, stroke, traumatic brain injury. 1.3 The patients who have psychotic symptoms. 1.4 Patients that have used drugs or stopped using drugs in less than one month. 2. Unipolar depressive disorder group (control) patients 2.1 The patients who have ever had manic or hypomanic episode. 2.2 The patients with a psychiatric emergency or unstable condition requiring urgent treatment. 2.3 The patients diagnosed with schizophrenia, schizoaffective disorder, neurodevelopmental disorders such as intellectual disabilities, autism spectrum disorder, neurocognitive disorders including delirium and dementia, stroke, traumatic brain injury. 2.4 The patients who have psychotic symptoms. 2.5 Patients that have used drugs or stopped using drugs in less than one month. 2.6 The pateints with a mood stabilizer such as antiepileptic drugs and lithium, patients with antipsychotic prescriptions.

Design outcomes

Primary

MeasureTime frame
bipolar diorder In the day participants are interview AuROC, LHR+

Secondary

MeasureTime frame
N/A N/A N/A

Countries

Thailand

Contacts

Public ContactAree Hinphet

faculty of medicine ,Naresuan university hospital

areeh@nu.ac.th0839522225

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026